Crossroads of Iron Metabolism and Inflammation in Colorectal Carcinogenesis: Molecular Mechanisms and Therapeutic Perspectives
Genes · 01.10.2025 · 16 (10) · 1166
DOI: 10.3390/genes16101166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 01.10.2025. Verfasst von Nahid Ahmadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Lorestan University of Medical Sciences, Kamalvand Campus, Khorramabad 6813833946, Iran. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Iron, Inflammation, Carcinogenesis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Iron metabolism and chronic inflammation are two interrelated processes that significantly influence the initiation and progression of CRC. Iron is essential for cell proliferation, but its excess promotes oxidative stress and DNA damage, while inflammation driven by cytokine-regulated pathways accelerates tumourigenesis. We therefore conducted this narrative review to collate the available evidence on the link between iron homeostasis and inflammatory signalling in CRC and highlight potential diagnostic and therapeutic applications.
Methods
This narrative review of preclinical and clinical studies explores the molecular and cellular pathways that connect iron regulation and inflammation to CRC. Key regulatory molecules, such as the transferrin receptor (TFRC), ferroportin (SLC40A1), ferritin (FTH/FTL), hepcidin, and IL-6, were reviewed. Additionally, we summarised the findings of transcriptomic, epigenomic, and proteomic studies. Relevant therapeutic approaches, including iron chelation, ferroptosis induction, and anti-inflammatory strategies, were also discussed.
Results
Evidence suggests that CRC cells exhibit altered iron metabolism, marked by the upregulation of transferrin receptor (TFRC), downregulation of ferroportin, and dysregulated expression of ferritin. Inflammatory mediators such as IL-6 activate hepcidin and STAT3 signalling, which reinforce intracellular iron retention and oxidative stress. Increased immune evasion, epithelial proliferation, and genomic instability appear to be linked to the interaction between inflammation and iron metabolism. Other promising biomarkers include ferritin, hepcidin, and composite gene expression signatures; however, their clinical application remains limited. Although several preclinical studies support the use of targeted iron therapies and combination approaches with anti-inflammatory agents or immunotherapy, there is a lack of comprehensive clinical validation confirming their efficacy and safety in humans.
Conclusion
Although preclinical studies suggest that iron metabolism and inflammatory signalling form an interconnected axis closely linked to CRC, translating this pathway into reliable clinical biomarkers and effective therapeutic strategies remains a significant challenge. Future biomarker-guided clinical trials are essential to determine the clinical relevance and to establish precision medicine strategies targeting the iron–inflammation crosstalk in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Lorestan University of Medical Sciences, Kamalvand Campus, Khorramabad 6813833946, Iran.
- School of Medicine & Dentistry, Griffith University, Gold Coast Campus, Southport, QLD 4222, Australia.
- Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya 20400, Sri Lanka.
ORCID-Profile: Nahid Ahmadi, Vinod Gopalan
Zitieren
APA
Ahmadi, N., Vidanapathirana, G., & Gopalan, V. (2025). Crossroads of Iron Metabolism and Inflammation in Colorectal Carcinogenesis: Molecular Mechanisms and Therapeutic Perspectives. Genes, 16(10), 1166. https://doi.org/10.3390/genes16101166
Vancouver
Ahmadi N, Vidanapathirana G, Gopalan V. Crossroads of Iron Metabolism and Inflammation in Colorectal Carcinogenesis: Molecular Mechanisms and Therapeutic Perspectives. Genes. 2025;16(10):1166. doi:10.3390/genes16101166
BibTeX
@article{Ahmadi2025,
author = {Ahmadi, Nahid and Vidanapathirana, Gihani and Gopalan, Vinod},
title = {Crossroads of Iron Metabolism and Inflammation in Colorectal Carcinogenesis: Molecular Mechanisms and Therapeutic Perspectives},
journal = {Genes},
year = {2025},
volume = {16},
number = {10},
pages = {1166},
doi = {10.3390/genes16101166}
}
EUVIMED